|
業務類別
|
Biotechnology |
|
業務概覽
|
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively. |
| 公司地址
| 117 Kendrick Street, Suite 450, Needham, MA, USA, 02494 |
| 電話號碼
| +1 617 916-5445 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.candeltx.com |
| 員工數量
| 55 |
| Ms. Seshu Tyagarajan, PhD,R.A.C. |
Chief Technical Officer and Chief Development Officer |
-- |
29/04/2026 |
| Dr. William Garrett Nichols, M.D.,M.S. |
Chief Medical Officer |
-- |
29/04/2026 |
| Mr. Charles Schoch |
Treasurer, Secretary, Chief Financial Officer and Principal Accounting Officer |
美元 398.50K |
29/04/2026 |
| Dr. Paul Peter Tak, M.D.,PhD |
President, Chief Executive Officer and Director |
美元 743.59K |
29/04/2026 |
| Dr. Francesca Barone, M.D.,PhD |
Chief Scienctific Officer |
美元 483.31K |
29/04/2026 |
|
|
| Mr. Joseph C. Papa, M.B.A.,R.Ph. |
Independent Director |
29/04/2026 |
| Dr. Mahalakshmi Radhakrishnan, M.D. |
Independent Director |
29/04/2026 |
| Mr. Paul B. Manning |
Chairman of the Board |
29/04/2026 |
| Dr. Edward J. Benz, Jr,M.D. |
Independent Director |
29/04/2026 |
| Ms. Renee M. Gaeta |
Independent Director |
29/04/2026 |
| Dr. Diem Nguyen, M.B.A.,PhD |
Independent Director |
29/04/2026 |
| Dr. Gary J. Nabel, M.D.,PhD |
Independent Director |
29/04/2026 |
| Dr. Paul Peter Tak, M.D.,PhD |
President, Chief Executive Officer and Director |
29/04/2026 |
| Mr. Christopher Martell |
Independent Director |
29/04/2026 |
| Dr. Nicoletta Loggia, PhD,R.Ph. |
Independent Director |
29/04/2026 |
|
|
|
|
